Horizon Therapeutics Public Limited Company (HZNP)
Growth
Revenue 5Y20.97%
Revenue 3Y29.59%
EPS 5Y35.24%
EPS 3Y98.90%
Dividend 5Y-
Dividend 3Y-
Capital Efficiency
ROIC8.28%
ROE11.80%
ROA6.36%
ROTA10.52%
Capital Structure
Market Cap25.27B
EV25.70B
Cash2.13B
Current Ratio3.96
Debt/Equity0.44
Net Debt/EBITDA0.41
HZNP
Income Statement
Select a metric from the list below to chart it
Dec '08
Dec '11
Dec '14
Dec '17
Dec '20
| Income Statement | Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 74.0 | 297.0 | 757.0 | 981.1 | 1,056.2 | 1,207.6 | 1,300.0 | 2,200.4 | 3,226.4 | 3,701.5 | |
| Revenue % Chg. | 277.0% | 301.2% | 154.9% | 29.6% | 7.7% | 14.3% | 7.7% | 69.3% | 46.6% | 25.2% | |
| Cost of Revenue | 14.6 | 78.8 | 219.5 | 393.3 | 546.3 | 422.3 | 362.2 | 532.7 | 794.5 | 920.9 | |
| Cost of Revenue % Chg. | 15.5% | 438.5% | 178.7% | 79.2% | 38.9% | -22.7% | -14.2% | 47.1% | 49.1% | 28.7% | |
| Gross Profit | 59.4 | 218.2 | 537.5 | 587.8 | 510.0 | 785.3 | 937.9 | 1,667.7 | 2,431.9 | 2,780.6 | |
| Gross Profit % Chg. | 752.2% | 267.4% | 146.4% | 9.4% | -13.3% | 54.0% | 19.4% | 77.8% | 45.8% | 24.0% | |
| Gross Profit Margin | 80.2% | 73.5% | 71.0% | 59.9% | 48.3% | 65.0% | 72.1% | 75.8% | 75.4% | 75.1% | |
| Gross Profit Margin % Chg. | 126.0% | -8.4% | -3.4% | -15.6% | -19.4% | 34.7% | 10.9% | 5.1% | -0.5% | -0.9% | |
| R&D Expenses | 10.1 | 17.5 | 41.9 | 60.7 | 225.0 | 82.8 | 103.2 | 209.4 | 432.0 | 461.4 | |
| R&D Expenses % Chg. | -40.1% | 73.1% | 139.8% | 45.0% | 270.6% | -63.2% | 24.7% | 102.9% | 106.3% | 27.5% | |
| Selling, General, & Admin Expenses | 92.2 | 209.2 | 440.3 | 608.3 | 677.4 | 692.5 | 697.1 | 973.2 | 1,446.4 | 1,586.5 | |
| Selling, General, & Admin Expenses % Chg. | 33.6% | 127.0% | 110.4% | 38.2% | 11.4% | 2.2% | 0.7% | 39.6% | 48.6% | 19.8% | |
| Operating Income | -42.9 | -8.5 | 55.4 | -147.2 | -392.4 | 2.4 | 126.6 | 490.0 | 543.1 | 676.6 | |
| Operating Income % Chg. | 45.7% | 80.2% | - | - | 166.6% | - | 5193.1% | 287.0% | 10.8% | 23.0% | |
| Operating Income Margin | -57.9% | -2.9% | 7.3% | -15.0% | -37.1% | 0.2% | 9.7% | 22.3% | 16.8% | 18.3% | |
| Operating Income Margin % Chg. | 85.6% | 95.1% | - | - | 147.7% | - | 4816.7% | 128.7% | -24.4% | -1.7% | |
| Total Other Income/Expenses Net | -107.3 | -261.2 | -188.1 | -80.9 | -120.9 | -121.5 | -146.8 | -88.4 | -80.3 | -92.9 | |
| Total Other Income/Expenses Net % Chg. | 661.2% | 143.5% | 28.0% | 57.0% | 49.4% | 0.5% | 20.8% | 39.8% | 9.1% | 35.1% | |
| Income Before Tax | -150.1 | -269.7 | -132.7 | -228.1 | -513.3 | -119.1 | -20.2 | 401.6 | 462.8 | 583.7 | |
| Income Before Tax % Chg. | 61.5% | 79.6% | 50.8% | 71.9% | 125.0% | 76.8% | 83.0% | - | 15.2% | 21.3% | |
| Income Before Tax Margin | -202.8% | -90.8% | -17.5% | -23.2% | -48.6% | -9.9% | -1.6% | 18.3% | 14.3% | 15.8% | |
| Income Before Tax Margin % Chg. | 57.2% | 55.2% | 80.7% | 32.6% | 109.0% | 79.7% | 84.2% | - | -21.4% | -3.1% | |
| Income Tax Expense | -1.1 | -6.1 | -172.2 | -61.3 | -102.7 | -45.0 | -593.2 | 11.8 | -71.7 | 9.4 | |
| Income Tax Expense % Chg. | 78.3% | 442.7% | 2731.1% | 64.4% | 67.8% | 56.2% | 1219.5% | - | - | - | |
| Net Income | -149.0 | -263.6 | 39.5 | -166.8 | -410.5 | -74.2 | 573.0 | 389.8 | 534.5 | 574.3 | |
| Net Income % Chg. | 69.7% | 76.9% | - | - | 146.1% | 81.9% | - | -32.0% | 37.1% | 4.1% | |
| Net Income Margin | -201.3% | -88.8% | 5.2% | -17.0% | -38.9% | -6.1% | 44.1% | 17.7% | 16.6% | 15.5% | |
| Net Income Margin % Chg. | 55.0% | 55.9% | - | - | 128.6% | 84.2% | - | -59.8% | -6.5% | -16.9% | |
| Weighted Avg. Shares Out | 63.7 | 83.8 | 148.8 | 160.7 | 163.1 | 166.2 | 182.9 | 204.0 | 204.0 | 229.1 | |
| Weighted Avg. Shares Out % Chg. | 63.8% | 31.6% | 77.7% | 8.0% | 1.5% | 1.9% | 10.1% | 11.5% | - | 2.3% | |
| EPS | -2.3 | -3.2 | 0.3 | -1.0 | -2.5 | -0.5 | 3.1 | 1.9 | 2.4 | 2.5 | |
| EPS % Chg. | 3.5% | 34.6% | - | - | 142.3% | 82.1% | - | -39.0% | 24.1% | 2.4% | |
| Weighted Avg. Shares Out Dil | 63.7 | 83.8 | 155.9 | 160.7 | 163.1 | 166.2 | 205.2 | 215.3 | 215.3 | 236.1 | |
| Weighted Avg. Shares Out Dil % Chg. | 63.8% | 31.6% | 86.2% | 3.1% | 1.5% | 1.9% | 23.5% | 4.9% | - | 1.7% | |
| EPS Diluted | -2.3 | -3.2 | 0.3 | -1.0 | -2.5 | -0.5 | 2.9 | 1.8 | 2.3 | 2.4 | |
| EPS Diluted % Chg. | 3.5% | 34.6% | - | - | 142.3% | 82.1% | - | -37.6% | 25.4% | 5.2% | |
| Interest Expense | 39.2 | 23.8 | 69.9 | 86.6 | 126.5 | 121.7 | 87.1 | 59.6 | 81.1 | 87.2 | |
| Interest Expense % Chg. | 169.7% | -39.2% | 193.4% | 23.9% | 46.1% | -3.8% | -28.4% | -31.5% | 36.0% | 23.6% | |
| EBIT | -189.3 | -293.5 | -202.6 | -314.7 | -639.8 | -240.8 | -107.3 | 342.0 | 381.8 | 496.5 | |
| EBIT % Chg. | 76.1% | 55.0% | 31.0% | 55.3% | 103.3% | 62.4% | 55.4% | - | 11.6% | 20.9% | |
| EBIT Margin | -255.8% | -98.8% | -26.8% | -32.1% | -60.6% | -19.9% | -8.3% | 15.5% | 11.8% | 13.4% | |
| EBIT Margin % Chg. | 53.3% | 61.4% | 72.9% | 19.8% | 88.8% | 67.1% | 58.6% | - | -23.9% | -3.4% | |
| Depreciation & Amortization | 9.3 | 34.0 | 138.3 | 221.8 | 283.4 | 275.7 | 237.2 | 279.5 | 353.8 | 388.2 | |
| Depreciation & Amortization % Chg. | 68.1% | 265.3% | 306.8% | 60.4% | 27.8% | -2.7% | -14.0% | 17.8% | 26.6% | 18.8% | |
| EBITDA | -180.0 | -259.5 | -64.3 | -92.9 | -356.4 | 34.9 | 129.8 | 621.5 | 735.5 | 884.6 | |
| EBITDA % Chg. | 76.5% | 44.2% | 75.2% | 44.5% | 283.8% | - | 272.1% | 378.6% | 18.3% | 19.9% | |
| EBITDA Margin | -243.2% | -87.4% | -8.5% | -9.5% | -33.7% | 2.9% | 10.0% | 28.2% | 22.8% | 23.9% | |
| EBITDA Margin % Chg. | 53.2% | 64.1% | 90.3% | 11.5% | 256.5% | - | 245.7% | 182.8% | -19.3% | -4.2% |